September 2026
The US stroke diagnostic and therapeutic market generated USD 6.97 billion in 2026, with prominent US stroke diagnostic and therapeutic market companies including Neural Analytics, Cordis Corporation, Cerebrotech Medical Systems, Inc., Koninklijke Philips N.V.
September 2026
The global stroke diagnostic and therapeutic market size is projected to hit around USD 90.62 billion by 2035 from USD 45.41 billion in 2026 with a CAGR of 7.98%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
September 2026
The global therapeutic hypothermia systems market size is estimated to hit around USD 509.19 million by 2035 increasing from USD 334.21 million in 2026, with a CAGR of 4.79%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 37.98 billion in 2026 with a CAGR of 7.22%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global central nervous system therapeutics market size is projected to hit around USD 285.72 billion by 2035 from USD 138.62 billion in 2026, with a CAGR of 8.64%
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The respiratory syncytial virus diagnostic market size stood at USD 1.67 billion in 2026, with major Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company (BD), Danaher Corporation (Cepheid) companies including respiratory syncytial virus diagnostic market.
September 2026
The global Duchenne muscular dystrophy therapeutics market size was evaluated at USD 7.80 billion in 2026 and is predicted to hit around USD 26.88 billion by 2035, growing at a CAGR of 14.80%.
September 2026
The global blood transfusion diagnostics market size was evaluated at USD 5.58 billion in 2026 and is predicted to hit around USD 8.79 billion by 2034, growing at a CAGR of 5.84%.
September 2026
The US peptide therapeutics market size stood at USD 22.63 billion in 2026, with major US peptide therapeutics market companies including AbbVie, GlaxoSmithKline plc., Amgen, Inc.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 6.01 billion in 2026 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
August 2026
The dental diagnostic and surgical equipment market size is projected to surpass around USD 23.59 billion by 2035 from USD 13.02 billion in 2025 with a CAGR of 6.12%
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
September 2026
The North America hereditary testing market was valued at USD 5.98 billion in 2025 and is expected to grow at a CAGR of 15.02% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The diagnostic tools market size reached USD 48.13 billion in 2026, with leading diagnostic tools market companies including Abbott Laboratories, bioMerieux SA.
September 2026
The global anti-obesity medication market was valued at USD 19.84 billion in 2025 and is expected to grow at a CAGR of 32% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 158.64 million in 2026, with a CAGR of 2.99%.
September 2026
The global ashwagandha market size is estimated to hit around USD 2,014.15 million by 2035, increasing from USD 915.38 million in 2026, with a CAGR of 9.17%.
September 2026
The global single-use bioprocessing connectors market size is accounted to hit around USD 6.34 billion by 2035 increasing from USD 1.74 billion in 2026, with a CAGR of 15.43%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com